SCHEMBL23048665

SCHEMBL23048665

CN1CCN(c2cc(C=C3CC3)ccn2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 6/20 0.52
▸ HRH3 Q9Y5N1 2/20 0.45
▸ HTR3A P46098 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.41
▸ RAD52 P43351 1/20 0.41
▸ UBE2N P61088 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ CYP1A2 P05177 6/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ HSD17B10 Q99714 4/20 0.41
▸ ALOX15 P16050 3/20 0.41
▸ CYP2D6 P10635 1/20 0.39
▸ PIM1 P11309 1/20 0.39
▸ GLA P06280 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23048624 0.85 DYRK1A (0.39) HRH4HRH3CYP1A2ALDH1A1HSD17B10
SCHEMBL19546591 0.83 HRH4 (0.56) HRH4HRH3HTR3AKDM4ERAD52
SCHEMBL19547056 0.81 HRH4 (0.55) HRH4HRH3HTR3AKDM4ERAD52
SCHEMBL23916158 0.80 HRH4 (0.54) HRH4HRH3HTR3AKDM4ERAD52
SCHEMBL27827453 0.80 HRH4 (0.54) HRH4HRH3HTR3AKDM4ERAD52
SCHEMBL23916096 0.80 HRH4 (0.54) HRH4HRH3HTR3AKDM4ERAD52
SCHEMBL23048862 0.75 HRH3 (0.40) HRH4HRH3
SCHEMBL10196855 0.74 HRH4 (0.61) HRH4HRH3HTR3AKDM4ERAD52
SCHEMBL23048716 0.73 KDM4E (0.32) KDM4E
SCHEMBL568726 0.72 HRH4 (0.46) HRH4HRH3HTR3AKDM4ERAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3448386-B1 ISOQUINOLIN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF SAMUMED LLC (US) 2021-03-03 — — EP disclosed
Send feedback